2-氨基-4-甲基恶唑，CAS 登记号 35629-70-0，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 2-氨基-4-甲基恶唑 的 CAS 号：35629-70-0，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
2-Amino-4-methyloxazole · CAS 35629-70-0 · C4H6N2O. UNII AM20090562.
| CAS Registry Number | 35629-70-0 |
|---|---|
| PubChem CID | 535824 |
| Molecular formula | C4H6N2O |
| IUPAC name | 4-methyl-1,3-oxazol-2-amine |
| UNII (FDA) | AM20090562 |
| Molecular Weight | 98.10 |
|---|---|
| XLogP3 | 0.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 0 |
| Exact Mass | 98.048012819 |
| Monoisotopic Mass | 98.048012819 |
| Topological Polar Surface Area | 52.1 |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Reported hazard statements | H302, H312, H332 (12.5%), H315 (75%), H318 (37.5%), H319 (37.5%), H335 (75%) |
|---|
H302+H312+H332 (12.5%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]
H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]
4-methyloxazol-2-amine; 35629-70-0; DTXSID10336726; RefChem:525629; DTXCID00287814; 640-955-6; 2-Amino-4-methyloxazole; 4-Methyl-1,3-oxazol-2-amine; 2-oxazolamine, 4-methyl-; 4-methyl-oxazol-2-ylamine; 4-methyl-2-oxazolamine; MFCD00126682; 2-Amino-4-methyl-oxazole; (4-methyl-oxazol-2-yl)-amine; 2-amino-4-methyloxazole, AldrichCPR; AKOS003669784
CAS 35629-70-0; molecular formula C4H6N2O; molecular weight — g/mol.
4-methyloxazol-2-amine, 35629-70-0, DTXSID10336726, RefChem:525629, DTXCID00287814, 640-955-6.
Hazard statements reported: H302, H312, H332, H315, H318.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.